A detailed history of Colton Groome Financial Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Colton Groome Financial Advisors, LLC holds 1,563 shares of JNJ stock, worth $242,280. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,563
Previous 1,615 3.22%
Holding current value
$242,280
Previous $236,000 7.2%
% of portfolio
0.09%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$145.48 - $167.38 $7,564 - $8,703
-52 Reduced 3.22%
1,563 $253,000
Q2 2024

Jul 24, 2024

SELL
$144.38 - $157.78 $75,077 - $82,045
-520 Reduced 24.36%
1,615 $236,000
Q1 2024

Apr 18, 2024

SELL
$155.22 - $162.74 $28,094 - $29,455
-181 Reduced 7.82%
2,135 $337,000
Q4 2023

Jan 31, 2024

BUY
$145.6 - $158.88 $82,992 - $90,561
570 Added 32.65%
2,316 $363,000
Q3 2023

Oct 23, 2023

SELL
$155.75 - $174.48 $10,746 - $12,039
-69 Reduced 3.8%
1,746 $271,000
Q2 2023

Jul 27, 2023

SELL
$154.35 - $166.11 $31,641 - $34,052
-205 Reduced 10.15%
1,815 $300,000
Q1 2023

Apr 17, 2023

BUY
$151.05 - $180.26 $12,537 - $14,961
83 Added 4.28%
2,020 $313,000
Q4 2022

Jan 25, 2023

BUY
$160.2 - $179.79 $28,355 - $31,822
177 Added 10.06%
1,937 $0
Q3 2022

Oct 20, 2022

BUY
$161.33 - $179.52 $16,133 - $17,952
100 Added 6.02%
1,760 $288,000
Q2 2022

Jul 26, 2022

BUY
$168.19 - $186.01 $46,252 - $51,152
275 Added 19.86%
1,660 $295,000
Q1 2022

Apr 18, 2022

SELL
$158.14 - $179.59 $772,197 - $876,937
-4,883 Reduced 77.9%
1,385 $245,000
Q4 2021

Jan 19, 2022

BUY
$155.93 - $173.01 $16,684 - $18,512
107 Added 1.74%
6,268 $1.07 Million
Q3 2021

Oct 18, 2021

BUY
$161.5 - $179.47 $14,535 - $16,152
90 Added 1.48%
6,161 $995,000
Q2 2021

Jul 21, 2021

BUY
$159.48 - $171.07 $968,203 - $1.04 Million
6,071 New
6,071 $1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Colton Groome Financial Advisors, LLC Portfolio

Follow Colton Groome Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colton Groome Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colton Groome Financial Advisors, LLC with notifications on news.